Filing Details

Accession Number:
0001062993-15-004792
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-26 16:03:05
Reporting Period:
2015-08-25
Filing Date:
2015-08-26
Accepted Time:
2015-08-26 16:03:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1098880 Intelgenx Technologies Corp. IGXT Pharmaceutical Preparations (2834) 870638336
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1381866 G Horst Zerbe 714 Main Rd.
Hudson A8 J0P1H0
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock ($0.00001 Par Value) Disposition 2015-08-25 36,900 $0.50 349,064 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock ($0.00001 Par Value) 4,238,679 Indirect See footnote
Footnotes
  1. In connection with the acquisition of IntelGenx in 2006, Horst Zerbe became our President, Chief Executive Officer and Director and acquired 4,709,643.5 exchangeable shares of our Canadian holding corporation 6544631Canada Inc., a Canadian special purpose corporation which wholly owns IntelGenx Corp. (the "Exchangeable Shares"). The Exchangeable Shares are exchangeable, on a one for one basis, into shares of common stock of IntelGenx Technologies Corp. at Horst Zerbe's discretion. As of today 470,964 exchangeable shares have been exchanged into common stock of IntelGenx Technologies Corp. Prior to exchanging the remaining Exchangeable Shares for shares of common stock, Horst Zerbe has the right to vote 4,238,679.5 shares of common stock which are currently held in trust on behalf of Horst Zerbe. The 4,709,643.5 shares of common stock have not been registered for resale at this time.